Gut fermentation of dietary fibres: implications for health

Studies have demonstrated a link between low levels of dietary fibre and the occurrence of chronic diseases including type 2 diabetes and cardiovascular disease.

Call for pharmacist access to the MBS for Chronic Disease Management

Pharmacists within general practice is a positive step forward, but the exclusion from MBS Team Care arrangements in CDM items makes no sense. After a...

PSA’s projects make a bigger impact than ever before

The PSA released its 2025 Strategic Projects Impact Report last week, showcasing its leadership in advancing pharmacist practice.

Treating hypertension – a new approach

Hypertension is the leading cause of cardiovascular disease, affecting 1.13 billion people worldwide, including six million adult Australians. Research has indicated that a new pharmacological...

Consultant pharmacist excellence awarded

Two pharmacists were honoured at PSA’s Consultant Pharmacist Conference (CPC26), held from 29–31 May 2026 on the Gold Coast.

Resistance movement: Pharmacy’s fight against antimicrobial resistance

Antimicrobial resistance (AMR) has been ranked as serious a threat to society as terrorism. With millions of lives at risk, and trillions in GDP...